Rocha, V., Mooyaart, J. E., Ram, R., Clesham, K., Daskalakis, M., Huynh, A., Potter, V., Chaganti, S., Gabellier, L., Tholouli, E., Collin, M., Nicholson, E., Protheroe, R., Passweg, J., Ayuk, F., Schneidawind, D., Kwon, M., Corral, L. L., Zeiser, R., Scheid, C., Yakoub-Agha, I., Dreger, P., Stolzel, F., Hoogenboom, J., Coelho, M. H. M., Tomas, A. A., Malard, F., Kuball, J., Sureda, A., Barzabachi, A. and Ruggeri, A. (2020) “Improved progression free survival after axicabtagene ciloleucel compared to tisagenlecleucel, in patients aged >70 years with large B-cell lymphoma”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.300508.